Chinese Traditional and Herbal Drugs
|
2025, 56(7): 2396-2411
Antithrombotic mechanism of Jingfang Mixture based on intestinal flora and metabolomics
Full
NI Wenting1,2, LI Shirong3, SUN Chenghong4, YAO Jingchun1,2, ZHANG Guimin1,2
Affiliations
1 Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, China;
2 Shandong University of Traditional Chinese Medicine, Jinan 250355, China;
3 Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;
4 Zaozhuang University, Zaozhuang 277160, China
doi: 10.7501/j.issn.0253-2670.2025.07.016
Outline
Objective To explore the antithrombotic mechanism of Jingfang Mixture (荆防合剂) based on intestinal flora and metabolomics. Methods A total of 48 rats were divided into control group, model group, Jingfang Mixture low-, medium-, high-dose groups and aspirin group, with eight rats in each group. Thrombus was caused by intraperitoneal injection of carrageenan combined with low-temperature induction. The drug was administered 7 d before modeling, anesthetized and sacrificed 48 h after modeling. The tail of rats was taken for hematoxylin-eosin (HE) and Masson staining, and the colon was stained for AB-PAS staining; Pasma was taken for four coagulation items; ELISA was used to detect the contents of thromboxane B2 (TXB2), 6-keto-PGF1α, antithrombin Ⅲ (ATⅢ), fibrinogen degradation products (FDP) in plasma and tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), interleukin-1β (IL-1β), IL-6 and intestinal secretory immunoglobulin A (SIgA) in serum; The contents of endotoxin (LPS), diamine oxidase (DAO) and D-lactic acid (D-LA) in intestinal mucosal barrier indicators were measured; qRT-PCR and Western blotting were used to detect the gene and protein expressions of intestinal zonula occludens proteins-1 (ZO-1) and Occludin; Changes in rat intestinal flora and endogenous metabolites were measured based on 16S rDNA high-throughput sequencing technology and non-targeted metabolomics. Results Jingfang Mixture could significantly reduce the relative black tail length of thrombotic rats (P < 0.05, 0.01), reduce inflammatory infiltration and collagen content in tail (P < 0.05, 0.01), regulate the levels of activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB), coagulation factors TXB2, 6-keto-PGF1α, ATIII, FDP (P < 0.05, 0.01), inflammatory factors TNF-α, IFN-γ, IL-1β, IL-6 (P < 0.05, 0.01) and intestinal SIgA (P < 0.05), reduce the levels of intestinal mucosa damage factors LPS, DAO, D-LA (P < 0.05, 0.01), and increase the expression levels of intestinal tight junction protein gene and protein (P < 0.05, 0.01). 16S rDNA and serum non-targeted metabolomic results showed that Jingfang Mixture could significantly improve intestinal flora disorders in rats with thrombosis, and its metabolic pathways may be related to the metabolism of unsaturated fatty acids and linoleic acid. Conclusion Jingfang Mixture has a good therapeutic effect on thromboticrats caused by carrageenan, as well as reducing pathological changes in rat tails, alleviating the imbalance of coagulation factors and inflammatory factors, improving intestinal barrier damage and intestinal flora disorders, and affecting related metabolic pathways such as unsaturated fatty acids.
Jingfang Mixture
/
thrombus
/
intestinal barrier
/
intestinal flora
/
metabolics
/
unsaturated fatty acid metabolism
倪雯婷, 李市荣, 孙成宏, 姚景春, 张贵民.
基于肠道菌群及代谢组学探讨荆防合剂抗血栓的作用机制.
中草药,
2025
, 56
(7)
: 2396
-2411
.
DOI: 10.7501/j.issn.0253-2670.2025.07.016
NI Wenting, LI Shirong, SUN Chenghong, YAO Jingchun, ZHANG Guimin.
Antithrombotic mechanism of Jingfang Mixture based on intestinal flora and metabolomics[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(7)
: 2396
-2411
.
DOI: 10.7501/j.issn.0253-2670.2025.07.016
Year 2025 volume 56 Issue 7
38
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.07.016
- Receive Date:2024-12-31
- Online Date:2026-11-13